Immunohistochemical markers, including EMA, cytokeratin, S100, CD1a, CD99, friend leukemia integration 1 protein (FLI1), neuron-specific enolase (NSE) and lymphoid markers, can be used to differentiate ALCL from other neoplasms. This evidence concerns the gene CD99 and anaplastic large cell lymphoma.